Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen M Taylor

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell ResponsesJamileh A Nabizadeh, Helga D Manthey, Frederik J Steyn, et al.
Experimental & Translational Stroke Medicine|August 13, 2010
Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal deathJohn Thundyil, Sung-Chun Tang, Eitan Okun, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationTrent M Woodruff, James W Crane, Lavinia M Proctor, et al.
Molecular Pharmacology|March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activityDarren R March, Lavinia M Proctor, Martin J Stoermer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2019
C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanomaJamileh A Nabizadeh, Helga D Manthey, Nadya Panagides, et al.
JCI Insight|May 3, 2019
Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2Faith H Brennan, Trisha Jogia, Ellen R Gillespie, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell ResponsesJamileh A Nabizadeh, Helga D Manthey, Frederik J Steyn, et al.
Experimental & Translational Stroke Medicine|August 13, 2010
Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal deathJohn Thundyil, Sung-Chun Tang, Eitan Okun, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationTrent M Woodruff, James W Crane, Lavinia M Proctor, et al.
Molecular Pharmacology|March 27, 2004
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activityDarren R March, Lavinia M Proctor, Martin J Stoermer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 13, 2019
C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanomaJamileh A Nabizadeh, Helga D Manthey, Nadya Panagides, et al.
JCI Insight|May 3, 2019
Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2Faith H Brennan, Trisha Jogia, Ellen R Gillespie, et al.
Pageof 7